Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia

1 Dec 2020

Abstract excerpt

OBJECTIVE: To systematically review the performance of soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), and the sFlt-1/PlGF ratio in predicting adverse outcomes in women with preeclampsia. DATA SOURCES: We performed a systematic search of MEDLINE, EMBASE, CINAHL, Cochrane, Scopus, ClinicalTrials.gov, and Emcare databases from 1989 to March 2019 to identify studies correlating sFlt-1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33278298
DOI: 10.1097/aog.0000000000004149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers and the Prediction of Adverse Outcomes in PreeclampsiaPMID 33278298Read ↗

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsiaSemantic proximity Read ↗

Clinical tools and biomarkers to predict preeclampsiaSemantic proximity Read ↗

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationSemantic proximity Read ↗

Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant womenSemantic proximity Read ↗

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trialSemantic proximity Read ↗

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of PregnancySemantic proximity Read ↗

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in PreeclampsiaSemantic proximity Read ↗

The sFlt-1:PlGF Ratio in Women with Suspected PreeclampsiaSemantic proximity Read ↗

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at RiskSemantic proximity Read ↗

An updated view on the origin and use of angiogenic biomarkers for preeclampsiaSemantic proximity Read ↗

Preeclampsia pathogenesis and prediction - where are we now: the focus on the role of galectins and miRNAsSemantic proximity Read ↗

Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.